Cargando…

3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel

Bedaquiline is a new drug of the diarylquinoline class that has proven to be clinically effective against drug-resistant tuberculosis, but has a cardiac liability (prolongation of the QT interval) due to its potent inhibition of the cardiac potassium channel protein hERG. Bedaquiline is highly lipop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sutherland, Hamish S., Tong, Amy S.T., Choi, Peter J., Blaser, Adrian, Conole, Daniel, Franzblau, Scott G., Lotlikar, Manisha U., Cooper, Christopher B., Upton, Anna M., Denny, William A., Palmer, Brian D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467547/ https://www.ncbi.nlm.nih.gov/pubmed/30803745 http://dx.doi.org/10.1016/j.bmc.2019.02.026

Ejemplares similares

Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline
por: Blaser, Adrian, et al.
Publicado: (2019)

Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles
por: Sutherland, Hamish S., et al.
Publicado: (2018)

TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus
por: Sarathy, Jickky Palmae, et al.
Publicado: (2020)

Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units
por: Choi, Peter J., et al.
Publicado: (2017)

Synthetic Studies to Help Elucidate the Metabolism of the Preclinical Candidate TBAJ-876—A Less Toxic and More Potent Analogue of Bedaquiline
por: Choi, Peter J., et al.
Publicado: (2020)

6-Cyano Analogues of Bedaquiline as Less Lipophilic and Potentially Safer Diarylquinolines for Tuberculosis
por: Tong, Amy S. T., et al.
Publicado: (2017)

Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis
por: Sutherland, Hamish S., et al.
Publicado: (2022)

Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis
por: Lu, Guo-Liang, et al.
Publicado: (2020)

The electric heart of hERG
por: Islas, León D.
Publicado: (2013)

An Update on the Structure of hERG
por: Butler, Andrew, et al.
Publicado: (2020)

Inhibition of the hERG Potassium Channel by a Methanesulphonate-Free E-4031 Analogue
por: Helliwell, Matthew V., et al.
Publicado: (2023)

The N-linker region of hERG1a upregulates hERG1b potassium channels
por: Johnson, Ashley A., et al.
Publicado: (2022)

hERG1a N-terminal eag domain–containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: A possible mechanism for long QT syndrome
por: Trudeau, Matthew C., et al.
Publicado: (2011)

Fluorescent analogues of BeKm-1 with high and specific activity against the hERG channel
por: Vasseur, Lucie, et al.
Publicado: (2019)

Electrophysiological characterization of the modified hERG(T) potassium channel used to obtain the first cryo‐EM hERG structure
por: Zhang, Yihong, et al.
Publicado: (2020)

Antituberculosis Drug Interactions with Membranes: A Biophysical Approach Applied to Bedaquiline
por: Pinheiro, Marina, et al.
Publicado: (2019)

An Insight into the Potassium Currents of hERG and Their Simulation
por: Guidelli, Rolando
Publicado: (2023)

Stereoselective Blockage of Quinidine and Quinine in the hERG Channel and the Effect of Their Rescue Potency on Drug-Induced hERG Trafficking Defect
por: Yan, Meng, et al.
Publicado: (2016)

Drug-likeness of linear pentamidine analogues and their impact on the hERG K(+) channel – correlation with structural features
por: Żołek, Teresa, et al.
Publicado: (2019)

Design and Stereochemical Research (DFT, ECD and Crystal Structure) of Novel Bedaquiline Analogs as Potent Antituberculosis Agents
por: Geng, Yiding, et al.
Publicado: (2016)

Potent hERG channel inhibition by sarizotan, an investigative treatment for Rett Syndrome
por: Cheng, Hongwei, et al.
Publicado: (2019)

The Interaction between hERG1 and β1 Integrins Modulates hERG1 Current in Different Pathological Cell Models
por: Chioccioli Altadonna, Ginevra, et al.
Publicado: (2022)

Na(+) Permeation and Block of hERG Potassium Channels
por: Gang, Hongying, et al.
Publicado: (2006)

Stereoselective Inhibition of the hERG1 Potassium Channel
por: Grilo, Liliana Sintra, et al.
Publicado: (2010)

Voltage-Dependent Gating of hERG Potassium Channels
por: Cheng, Yen May, et al.
Publicado: (2012)

Long-Chain Acylcarnitines Regulate the hERG Channel
por: Ferro, Fabio, et al.
Publicado: (2012)

hERG channel function: beyond long QT
por: Babcock, Joseph J, et al.
Publicado: (2013)

Towards a complete structure of the hERG channel
por: Schmidtke, Peter, et al.
Publicado: (2013)

Ion Conduction through the hERG Potassium Channel
por: Ceccarini, Luisa, et al.
Publicado: (2012)

Kv4.3 Modulates the Distribution of hERG
por: Zhao, Xiao-Jing, et al.
Publicado: (2017)

Lipid regulation of hERG1 channel function
por: Miranda, Williams E., et al.
Publicado: (2021)

Trafficking-Deficient G572R-hERG and E637K-hERG Activate Stress and Clearance Pathways in Endoplasmic Reticulum
por: Wang, Ying, et al.
Publicado: (2012)

Support Vector Machine model for hERG inhibitory activities based on the integrated hERG database using descriptor selection by NSGA-II
por: Ogura, Keiji, et al.
Publicado: (2019)

Mitragynine, an euphoric compound inhibits hERG1a/1b channel current and upregulates the complexation of hERG1a-Hsp90 in HEK293-hERG1a/1b cells
por: Tay, Yea Lu, et al.
Publicado: (2019)

Application of Chiral Transfer Reagents to Improve Stereoselectivity and Yields in the Synthesis of the Antituberculosis Drug Bedaquiline
por: Robey, Juliana M. S., et al.
Publicado: (2023)

Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups
por: Pillozzi, S, et al.
Publicado: (2014)

Gating Charges in the Activation and Inactivation Processes of the hERG Channel
por: Zhang, Mei, et al.
Publicado: (2004)

Saxitoxin Is a Gating Modifier of hERG K(+) Channels
por: Wang, Jixin, et al.
Publicado: (2003)

Inhibition of hERG Potassium Channels by Celecoxib and Its Mechanism
por: Frolov, Roman V., et al.
Publicado: (2011)

Modification of hERG1 channel gating by Cd(2+)
por: Abbruzzese, Jennifer, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_59a8dmsetndlj4nppaemsp1eu3